| Filed On | Filing |
|---|---|
| 05 Nov 2026 | 10-Q |
| 04 Nov 2026 |
8-K: Results of Operations and Financial Condition
BURLINGTON, MA, November 4, 2026 – LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q3 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance. |
| 15 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
(b) On October 9, 2026, David B. Roberts notified LeMaitre Vascular, Inc. (the “Company”) of his intent to retire as an employee of the Company, including as its President, effective as of December 31, 2026. Mr. Roberts was reelected as ... |
| 08 Sep 2026 |
Form 4: Roberts David B, Director
Granted 24.9076 Dividend Equivalent Rights |
| 08 Sep 2026 |
Form 4: Pellegrino Joseph P Jr, Director
Granted 22.3137 Dividend Equivalent Rights |
| 08 Sep 2026 |
Form 4: Jasinski Lawrence J, Director
Granted 4.7443 Dividend Equivalent Rights |
| 08 Sep 2026 |
Form 4: Shadan Martha, Director
Granted 4.7443 Dividend Equivalent Rights |
| 08 Sep 2026 |
Form 4: O'Connor John James, Director
Granted 4.7443 Dividend Equivalent Rights |
| 08 Sep 2026 |
Form 4: LeBlanc Dorian Paul, Chief Financial Officer
Granted 6.5593 Dividend Equivalent Rights |
| 08 Sep 2026 |
Form 4: LeMaitre George W, Director
Granted 71.4165 Dividend Equivalent Rights |
| 08 Sep 2026 |
Form 4: Kamke Trent G, Senior V. P., Operations
Granted 13.8555 Dividend Equivalent Rights |
| 08 Sep 2026 |
Form 4: Roush John A, Director
Granted 4.7443 Dividend Equivalent Rights |
| 03 Sep 2026 |
Form 4: Roush John A, Director
Received 3,444 shares by exercise or conversion ($167K) |
| 05 Aug 2026 | 10-Q |
| 04 Aug 2026 |
8-K: Results of Operations and Financial Condition
BURLINGTON, MA, August 4, 2026 – LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance. |
| 29 Jul 2026 | 144 |
| 27 Jul 2026 | SCHEDULE 13G |
| 05 Jun 2026 |
Form 4: Jasinski Lawrence J, Director
Granted 4.0705 Dividend Equivalent Rights |
| 05 Jun 2026 |
Form 4: O'Connor John James, Director
Granted 4.0705 Dividend Equivalent Rights |
| 05 Jun 2026 |
Form 4: Roush John A, Director
Granted 4.0705 Dividend Equivalent Rights |
Loading...